# HCG Manavata Cancer Centre – FDA Inspection, Sep 27, 2019

Source: https://www.keypedia.com/records/fda_inspections/hcg-manavata-cancer-centre/a76202ca-498f-4f7f-8af7-b93d755227ca
Source feed: FDA_Inspections

> FDA inspection 1102925 of HCG Manavata Cancer Centre, September 27, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102925
- Company Name: HCG Manavata Cancer Centre
- Inspection Date: 2019-09-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1221683 - 2023-09-27](https://www.keypedia.com/records/fda_inspections/hcg-manavata-cancer-centre/f8215b21-25f6-415d-bc0d-07953504d70f)
- FDA Inspection 1179266 - 2022-08-06

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/janete-f-guardia/2405f83f-7ea9-4056-afbd-7d9c00a6e169)

Company: https://www.keypedia.com/companies/hcg-manavata-cancer-centre/b5266eff-a6f7-4c2f-b649-63920b7d709e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c